Cataract Clinical Trials

Find Cataract Clinical Trials Near You

Guiding the Treatment of Anterior Eye Diseases With Optical Coherence Tomography

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The long-term goal of this project is to utilize very high-speed optical coherence tomography (OCT) technology to guide surgical treatments of corneal diseases. OCT is well known for its exquisite resolution, but until recently it has not had sufficient speed to capture the shape of the cornea because of eye motion during OCT scanning. The development of Fourier-domain (FD) OCT technology has made the requisite speed possible. The objective of this project is to develop methods for imaging the cornea with an FD-OCT system that will precisely measure corneal shape and use this information to guide surgery. Cataract surgery in patients with previous laser vision correction often leads to significant near- or far-sightedness, a problem that could be resolved by using a more accurate intraocular lens power selection formula based on the measurement of corneal refractive power with OCT.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• The subjects will be patients seeking cataract surgery with implantation of monofocal IOLs (including toric IOLs) but not multifocal or accommodative IOLs.

• Subjects will have had post-laser vision correction (LVC) such as previous LASIK, PRK, laser sub-epithelial keratectomy (LASEK), epi-LASIK (surface laser ablation under a microkeratome-created epithelial flap) or RK. The post-LVC group will be subdivided into those who have previous hyperopic LVC and those who have previous myopic LVC.

Locations
United States
Oregon
Casey Eye Institute, Oregon Health & Science University
RECRUITING
Portland
Contact Information
Primary
Humberto Martinez, COT
martinhu@ohsu.edu
503-494-7712
Backup
Denny Romfh, OD
romfhd@ohsu.edu
503-494-4351
Time Frame
Start Date: 2011-04
Estimated Completion Date: 2026-07
Participants
Target number of participants: 690
Authors
Related Therapeutic Areas
Sponsors
Collaborators: National Eye Institute (NEI)
Leads: Oregon Health and Science University

This content was sourced from clinicaltrials.gov